市场调查报告书
商品编码
1468151
2024-2032 年眼科黏弹性器材市场(按产品、应用、最终用户和地区划分)Ophthalmic Viscoelastic Devices Market by Product, Application, End User, and Region 2024-2032 |
IMARC Group年,全球眼科黏弹性器械(OVD)市场规模达27亿美元。眼科手术数量的增加、广泛的研发 (R&D) 活动以及医疗保健行业的不断增长是推动市场发展的一些关键因素。
眼科黏弹性装置(OVD)是眼科手术期间使用的医疗设备。它们用于眼科和许多眼科手术,例如青光眼、角膜移植、玻璃体视网膜和白内障手术。这些装置可保护眼部结构免受机械创伤、分割组织、创造空间、解决沾黏、作为润湿剂或作为促进外科手术的器械。 OVD 广泛用于在人工水晶体 (IOL) 植入过程中维持眼内空间、稳定和加深前房以及在眼前节手术过程中保护眼部结构。这些设备有助于在前房内产生压力,划分注意力,并提供更快、更安全的手术,让患者更好地康復。
全球眼科手术数量的增加是推动市场成长的关键因素之一。 OVD 广泛用于维持、保留空间、置换、稳定和保护组织。与此一致,改善眼科护理设施的可近性和提高对眼部疾病的认识是另一个促进成长的因素。此外,由于复杂眼科手术病例数量的增加,黏性适应性眼科黏性手术设备的广泛使用及其消除对两个注射器的需求的双相优势正在推动市场成长。除此之外,黏性适应性OVD在复杂的眼科手术中也是首选,例如小儿白内障手术、虹膜鬆弛综合症患者、外伤、Fuchs营养不良等,以避免术后併发症,这反过来又有利于市场增长。除此之外,引入包含在单一单位中的黏性和分散OVD 组合包,该组合包在手术过程中同时使用,具有成本效益,可确保品质标准并简化眼外科医生的活动,这为市场提供了动力生长。此外,老年人口的增加以及糖尿病和与年龄相关的眼部疾病盛行率的增加正在对市场成长产生积极影响。其他因素包括消费者支出能力的提高、广泛的研发(R&D)活动、医疗保健行业的显着扩张,以及政府实施各种倡议,透过迫使生产商引进新的眼科设备来控制日益严重的视力损害。为市场创造积极的前景。
The global ophthalmic viscoelastic devices (OVD) market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.52% during 2024-2032. The increasing number of ophthalmic surgeries, extensive research and development (R&D) activities, and escalating growth in the healthcare industry represent some of the key factors driving the market.
Ophthalmic viscoelastic devices (OVD) are medical equipment used during eye surgeries. They are employed in ophthalmic and numerous eye surgeries, such as glaucoma, corneal transplant, and vitreoretinal and cataract surgery. These devices protect ocular structures from mechanical trauma, divide tissue, create space, resolve adhesions, act as a wetting agent, or as an instrument to facilitate the surgical procedure. OVDs are widely used to maintain space in the eye during intraocular lens (IOL) implantation, stabilize and deepen the anterior chamber, and protect ocular structures during anterior segment surgery. These devices assist in creating pressure within the anterior chamber, compartmentalizing inside the attention, and providing a faster and safer surgery with better recovery for the patients.
The increasing number of ophthalmic surgeries across the globe is one of the key factors driving the market growth. OVDs are widely used to maintain, preserve space, displace, stabilize, and protect tissues. In line with this, improving access to ophthalmic care facilities and rising awareness about ocular disorders are acting as another growth-inducing factor. Moreover, the widespread utilization of viscoadaptive ophthalmic viscosurgical devices due to the increasing number of complex ocular surgical cases and its biphasic benefit of eliminating the need for two syringes is propelling the market growth. In addition to this, viscoadaptive OVD is also preferred in complex ocular surgeries, such as pediatric cataract surgery, patient with floppy iris syndrome, trauma, Fuchs dystrophy, and other cases to avoid post-surgical complications, which, in turn, is favoring the market growth. Apart from this, the introduction of a combination package of cohesive and dispersive OVD contained in a single unit, that is used simultaneously during procedures and is cost-effective, ensures quality standards and eases out ophthalmic surgeons' activities is providing an impetus to the market growth. Additionally, the rising geriatric population and the increasing prevalence of diabetes and age-related ocular disorders are positively influencing the market growth. Other factors, including the rising expenditure capacities of consumers, extensive research and development (R&D) activities, significant expansion in the healthcare industry, and the implementation of various government initiatives to control the rising vision impairment by compelling producers to introduce new ophthalmic equipment, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each segment of the global ophthalmic viscoelastic devices (OVD) market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, application, and end user.
Cohesive Ophthalmic Viscoelastic
Dispersive Ophthalmic Viscoelastic
A detailed breakup and analysis of the ophthalmic viscoelastic devices (OVD) market based on the product has also been provided in the report. This includes cohesive and dispersive ophthalmic viscoelastic. According to the report, cohesive ophthalmic viscoelastic accounted for the largest market share.
Cataract Surgery
Glaucoma Surgery
Corneal Transplant
Vitreoretinal Surgery
The report has provided a detailed breakup and analysis of the ophthalmic viscoelastic devices (OVD) market based on the application. This includes cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery. According to the report, cataract surgery represented the largest segment.
Hospitals
Ophthalmic Clinics
Others
A detailed breakup and analysis of the ophthalmic viscoelastic devices (OVD) market based on the end user has also been provided in the report. This includes hospitals, ophthalmic clinics, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for ophthalmic viscoelastic devices (OVD). Some of the factors driving the North America ophthalmic viscoelastic devices (OVD) market included extensive research and development (R&D) activities, the rising geriatric population, and the increasing prevalence of diabetes and age-related ocular disorders.
The report has also provided a comprehensive analysis of the competitive landscape in the global ophthalmic viscoelastic devices (OVD) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Alcon Inc., Altacor Limited, Bausch Health Companies Inc., Bohus Biotech Ab, Carl Zeiss Meditec Ag, Cima Technology Inc, Eyekon Medical Inc., Johnson & Johnson, RUMEX International Co., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.